Study of ABT-869 in Combination With Tarceva in Subjects With Solid Tumors

NCT00754104 · clinicaltrials.gov ↗

PHASE1

Phase

WITHDRAWN

Status

INDUSTRY

Sponsor class

Conditions

Solid Tumors

Interventions

DRUG: ABT-869
DRUG: Tarceva

Sponsor

Abbott

Collaborators

[object Object]